TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
256
|
267
|
260 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
14
|
49
|
73 |
EBITDA |
17
|
49
|
67 |
Total assets |
192
|
138
|
142 |
Current assets |
156
|
120
|
30 |
Current liabilities |
67
|
23
|
33 |
Equity capital |
124
|
115
|
109 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
3
![]() |
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
64.6%
|
83.3%
|
76.8% |
Turnover per employee |
85
|
89
|
130 |
Profit as a percentage of turnover |
5.5%
|
18.4%
|
28.1% |
Return on assets (ROA) |
7.3%
|
35.5%
|
51.4% |
Current ratio |
232.8%
|
521.7%
|
90.9% |
Return on equity (ROE) |
11.3%
|
42.6%
|
67.0% |
Change turnover |
-11
|
27
|
14 |
Change turnover % |
-4%
|
11%
|
6% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.